April 23, 2008
Amyris and Crystalsev Join to Launch Innovative Renewable Diesel from Sugarcane by 2010

Amyris, the leading innovator of next-generation renewable fuels, and Crystalsev, one of Brazil's largest ethanol distributors and marketers, today announced plans to commercialize advanced renewable fuels made from sugarcane including a diesel, jet fuel and gasoline. more>>

March 3, 2008
OneWorld Health, Amyris and Sanofi-aventis Announce Development Agreement for Semisynthetic Artemisinin

The Institute for OneWorld Health (iOWH), the US-based nonprofit pharmaceutical company, together with synthetic biology innovator Amyris, and leading pharmaceutical company sanofi-aventis today announced they have entered into an agreement for the development of semisynthetic artemisinin, a key ingredient in first-line malaria treatments.more>>

January 28, 2008
AMYRIS NAMES JERYL L. HILLEMAN CHIEF FINANCIAL OFFICER

Amyris, an innovator in the development of sustainable hydrocarbon biofuels, today announced that it has appointed Jeryl L. Hilleman to the new position of Chief Financial Officer.more>>

December 5, 2007
AMYRIS APPOINTS INDUSTRY EXPERT TO LEAD MANUFACTURING

Amyris, an innovator in the development of sustainable hydrocarbon biofuels, today announced that Jeff Lievense Ph.D. will join as Senior Vice President of Process Development and Manufacturing. more>>

September 19, 2007
AMYRIS BIOTECHNOLOGIES ANNOUNCES $70 MILLION SERIES B ROUND

Amyris Biotechnologies, an innovator in the development of renewable hydrocarbon biofuels, today announced that it closed the first tranche of its $70 million Series B funding. more>>

August 15, 2007
AMYRIS BIOTECHNOLOGIES CO-FOUNDER NEIL RENNINGER NAMED TO TECHNOLOGY REVIEW'S PRESTIGIOUS TR35 LIST OF TOP YOUNG INNOVATORS

Amyris Biotechnologies is pleased to announce that Neil Renninger, Ph.D., co-founder and senior vice president of development, has been recognized by Technology Review magazine as one of the world’s top innovators under the age of 35. more>>

June 26, 2007
AMYRIS BIOTECHNOLOGIES ANNOUNCES NEW BOARD MEMBER AND ADDITIONS TO ITS BIOFUELS MANAGEMENT TEAM

Amyris announces the addition of energy industry veteran Ralph Alexander to its Board of Directors as well as key additions of Paul Adams, Jim Alderman, and Ena Cratsenburg to its senior management team. more>>

October 12, 2006
AMYRIS BIOTECHNOLOGIES RAISES $20 MILLION IN SERIES A FUNDING; APPOINTS JOHN G. MELO CHIEF EXECUTIVE OFFICER - Synthetic Biology Pioneer Expands into Bioenergy Field

Amyris Biotechnologies, Inc., a privately-held company applying advances in synthetic biology to produce high-value pharmaceuticals, fine chemicals and biofuels, today announced that the company has raised $20 million in a first round of venture funding. The financing was led by Khosla Ventures, with additional participation from Kleiner Perkins Caufield & Byers (KPCB), and TPG Ventures (TPGV). The company also announced the appointment of John G. Melo, previously president of U.S. Fuels Operations for BP plc., as chief executive officer.more>>

April 12, 2006
U.C. Berkeley and Amyris Biotechnologies Collaborate to Demonstrate Microbial Production of Artemisinin

Research conducted at the University of California, Berkeley, in collaboration with Amyris Biotechnologies, Inc., has demonstrated the production of artemisinic acid in microbes, according to a report in the journal Nature. This work represents a key technical milestone for a three-part collaboration between UC Berkeley, Amyris and the Institute for One World Health (iOWH). more>>

Dec 5, 2005
World Economic Forum Selects Amyris Biotechnologies as Technology Pioneer for 2006

Amyris Biotechnologies, Inc. today announced that it has been selected by The World Economic Forum as one of 36 Technology Pioneers for 2006. Honoured in the Biotechnology/Health category, Amyris Biotechnologies is applying advances in synthetic biology to provide a consistent, cost-effective supply of high-value natural compounds for application as pharmaceuticals, nutraceuticals and fine chemicals. more>>

Nov 15, 2005
Amyris Biotechnologies Named Winner of 2005 World Technology Award for Biotechnology by the World Technology Network

On November 15, 2005, The World Technology Network (WTN) named Amyris Biotechnologies a corporate member and the winner of the 2005 World Technology Award for Biotechnology. The World Technology Awards honors individuals and corporations from 10 technology-related sectors viewed by their peers as being the most innovative and whose work has the greatest likelihood of long-term significance. more>>

Dec 13, 2004
$42.6 Million Five-Year Grant from Gates Foundation for Antimalarial Drug Brings Together Unique Collaboration of Biotech, Academia and NonProfit Pharma.

A $42.6 million grant from the Bill & Melinda Gates Foundation to the Institute for OneWorld Health, the first nonprofit pharmaceutical company in the United States, will create a powerful new approach to developing a more affordable, accessible cure for malaria, which kills more than a million children each year. more>>